title: A new standard of care for treatment of ovarian cancer.
authors.affiliation: Institut Jules Bordet, Unite de Cancerologie Mammaire et Gynecologie, Brussels, Belgium. mpiccart@ulb.ac.be
authors.forename: M J
authors.initials: MJ
authors.lastname: Piccart
authors.forename: A
authors.initials: A
authors.lastname: Du Bois
authors.forename: M E
authors.initials: ME
authors.lastname: Gore
authors.forename: J P
authors.initials: JP
authors.lastname: Neijt
authors.forename: S
authors.initials: S
authors.lastname: Pecorelli
authors.forename: E
authors.initials: E
authors.lastname: Pujade-Lauraine
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000008:administration & dosage; D011787:Quality of Health Care; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis
chemical_list: D016190:Carboplatin; D017239:Paclitaxel; D002945:Cisplatin